Karl Birthistle
Profile
Karl Birthistle worked as a Director of Clinical Development & Safety Assessments at Philip Morris International Management SA, Deputy Head of Division Clinical Review at Swissmedic, and Vice President of Clinical & Regulatory Affairs at Abivax SA.
Former positions of Karl Birthistle
Companies | Position | End |
---|---|---|
ABIVAX | General Counsel | 2017-03-31 |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Corporate Officer/Principal | - |
Philip Morris International Management SA
Philip Morris International Management SA TobaccoConsumer Non-Durables Philip Morris International Management SA produces and markets cigarettes and other tobacco products. Its cigarette brands include Marlboro, L&M, Philip Morris, Bond Street, Chesterfield, Parliament, Lark, Merit and Virginia Slims. The company was founded in 1961 and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
ABIVAX | Health Technology |
Private companies | 2 |
---|---|
Philip Morris International Management SA
Philip Morris International Management SA TobaccoConsumer Non-Durables Philip Morris International Management SA produces and markets cigarettes and other tobacco products. Its cigarette brands include Marlboro, L&M, Philip Morris, Bond Street, Chesterfield, Parliament, Lark, Merit and Virginia Slims. The company was founded in 1961 and is headquartered in Lausanne, Switzerland. | Consumer Non-Durables |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Karl Birthistle